Prolaeis®

Broad-Spectrum Mitigant with Anti-inflammatory properties

A highly refined form of monoglycerides. Prolaeis is another solution to reduce the risk of lipid-membraned viruses such as, PRRS, African Swine Fever and HPAI.

  • Monoglycerides significantly reduce infective loads of lipid-membraned viruses
  • Reduces challenges from gram-positive pathogens like Pneumococci, Staph. and Strep.
  • Reduces inflammation, allowing energy to be used for more productive processes.

See the newest research and access the SDS here.